@article{Liedert2007,
  added-at = {2011-03-22T09:11:06.000+0100},
  author = {Liedert, B and Bassus, S and Schneider, C K and Kalinke, U and Lower, J},
  biburl = {https://www.bibsonomy.org/bibtex/2a1a20165c9605e75571cf567034151a7/kalinke},
  editor = {Ther, Int J Clin Pharmacol},
  groups = {public},
  interhash = {f6167a3d4fcbf1c86bc72c39f28cc164},
  intrahash = {a1a20165c9605e75571cf567034151a7},
  journal = {Int J Clin Pharmacol Ther},
  keywords = {kalinke},
  number = 1,
  pages = {1-9},
  pubmedurl = {http://www.ncbi.nlm.nih.gov/pubmed/17256444},
  timestamp = {2012-05-31T12:07:34.000+0200},
  title = {Safety of phase I clinical trials with monoclonal antibodies in Germany--the regulatory requirements viewed in the aftermath of the TGN1412 disaster},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/17256444},
  username = {kalinke},
  volume = 45,
  year = 2007
}